Brachytherapy in the Treatment of Skin Cancer: an Overview

Overview

Journal Postepy Dermatol Alergol

Publisher Termedia

Specialty Allergy & Immunology

Date 2016 Jan 14

PMID 26759545

Citations 37

Authors

Janusz Skowronek

Affiliations

Soon will be listed here.

Abstract

The incidence of skin cancer worldwide is constantly growing and it is the most frequently diagnosed tumor. Brachytherapy (BT) in particular localizations is a valuable tool of the exact radiation depot inside the tumor mass. In localizations such as the face, skull skin and inoperable tumors, relapses after surgery, radiotherapy are usually not suitable for primary or secondary invasive treatment. Brachytherapy is a safe procedure for organs at risk according to rapid fall of a dose outside the axis of the applicator with satisfactory dose localization inside the target. The complications rate is acceptable and treatment costs are low. In some tumors (great skin lesions in the scalp, near eyes or on the nose) BT allows for a great dose reduction in surrounding healthy tissues. Brachytherapy provides minimal dose delivery to surrounding healthy tissue, thus enabling good functional and cosmetic results. Treatment is possible almost in all cases on an outpatient basis.

Citing Articles

Individualized 3D printing for skin cancer brachytherapy: Development, implementation, clinical applications, and treatment assessment.

Poltorak M, Banatkiewicz P, Poltorak L, Sobolewski P, Zimon D, Szwast M J Contemp Brachytherapy. 2024; 16(3):173-183.

PMID: 39629095 PMC: 11609861. DOI: 10.5114/jcb.2024.141420.

Image-Guided Radiation Therapy Is Equally Effective for Basal and Squamous Cell Carcinoma.

McClure E, Cockerell C, Hammond S, Marienberg E, Koneru B, Ward J Dermatopathology (Basel). 2024; 11(4):315-329.

PMID: 39584849 PMC: 11587017. DOI: 10.3390/dermatopathology11040033.

Freedom from Recurrence across Age in Non-Melanoma Skin Cancer Treated with Image-Guided Superficial Radiation Therapy.

Farberg A, Heysek R, Haber R, Agha R, Crawford K, Xinge J Geriatrics (Basel). 2024; 9(5).

PMID: 39311239 PMC: 11417751. DOI: 10.3390/geriatrics9050114.

Brachytherapy and 3D printing for skin cancer: A review paper.

Poltorak M, Banatkiewicz P, Poltorak L, Sobolewski P, Zimon D, Szwast M J Contemp Brachytherapy. 2024; 16(2):156-169.

PMID: 38808207 PMC: 11129648. DOI: 10.5114/jcb.2024.137357.

Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience.

Dibs K, Gogineni E, Jhawar S, Baliga S, Grecula J, Mitchell D Cancers (Basel). 2024; 16(4).

PMID: 38398079 PMC: 10887235. DOI: 10.3390/cancers16040688.

References

Alam M, Nanda S, Mittal B, Kim N, Yoo S . The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol. 2011; 65(2):377-388. DOI: 10.1016/j.jaad.2010.03.027. View

Szewczyk M, Pazdrowski J, Danczak-Pazdrowska A, Golusinski P, Majchrzak E, Luczewski L . Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma. Postepy Dermatol Alergol. 2014; 31(3):146-51. PMC: 4112263. DOI: 10.5114/pdia.2014.40959. View

Garcia-Martinez T, Chan J, Perez-Calatayud J, Ballester F . Dosimetric characteristics of a new unit for electronic skin brachytherapy. J Contemp Brachytherapy. 2014; 6(1):45-53. PMC: 4003426. DOI: 10.5114/jcb.2014.40770. View

Delannes M, Rio E, Mirabel X, Brun T, Ducassou A, David I . [Brachytherapy for cutaneous and lip carcinomas]. Cancer Radiother. 2013; 17(2):136-9. DOI: 10.1016/j.canrad.2013.02.003. View

Lliso F, Granero D, Perez-Calatayud J, Carmona V, Pujades M, Ballester F . Dosimetric evaluation of internal shielding in a high dose rate skin applicator. J Contemp Brachytherapy. 2016; 3(1):32-35. PMC: 5108835. DOI: 10.5114/jcb.2011.21041. View

Gauden R, Pracy M, Avery A, Hodgetts I, Gauden S . HDR brachytherapy for superficial non-melanoma skin cancers. J Med Imaging Radiat Oncol. 2013; 57(2):212-7. DOI: 10.1111/j.1754-9485.2012.02466.x. View

Sobjanek M, Dobosz M, Peksa R, Sokolowska-Wojdylo M, Kowalczyk A, Michajlowski I . Lymphoepithelioma-like carcinoma of the skin in a Polish patient. Postepy Dermatol Alergol. 2015; 32(1):56-8. PMC: 4360005. DOI: 10.5114/pdia.2014.40952. View

Tormo A, Celada F, Rodriguez S, Botella R, Ballesta A, Kasper M . Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy. 2014; 6(2):167-72. PMC: 4105643. DOI: 10.5114/jcb.2014.43247. View

Nag S, Cano E, Demanes D, Puthawala A, Vikram B . The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2001; 50(5):1190-8. DOI: 10.1016/s0360-3016(01)01567-x. View

10.

Lasota J, Kabacinska R, Makarewicz R . Dose estimation for different skin models in interstitial breast brachytherapy. J Contemp Brachytherapy. 2014; 6(2):200-7. PMC: 4105640. DOI: 10.5114/jcb.2014.43167. View

11.

Malicki J, LOBODZIEC W, Slosarek K . Dose-rate distribution under partially shielded beams. Strahlenther Onkol. 1990; 166(11):733-7. View

12.

DEBOIS J . Cesium-137 brachytherapy for epithelioma of the skin of the nose: experience with 370 patients. J Belge Radiol. 1994; 77(1):1-4. View

13.

Marek L, Grzanka A, Chmielowska E, Jankowski M, Schwartz R, Czajkowski R . Merkel cell carcinoma: an illustrative case and review. Postepy Dermatol Alergol. 2014; 31(5):325-8. PMC: 4221346. DOI: 10.5114/pdia.2014.40797. View

14.

Kanikowski M, Skowronek J, Chichel A . HDR brachytherapy of prostate cancer - two years experience in Greater Poland Cancer Centre. J Contemp Brachytherapy. 2009; 1(3):137-144. PMC: 5086480. View

15.

Crook J, Mazeron J, Marinello G, Raynal M, Huart J, Leung S . Interstitial iridium 192 for cutaneous carcinoma of the external nose. Int J Radiat Oncol Biol Phys. 1990; 18(1):243-8. DOI: 10.1016/0360-3016(90)90289-v. View

16.

Ashby M, Pacella J, de Groot R, Ainslie J . Use of a radon mould technique for skin cancer: results from the Peter MacCallum Cancer Institute (1975-1984). Br J Radiol. 1989; 62(739):608-12. DOI: 10.1259/0007-1285-62-739-608. View

17.

Sopata M, Tomaszewska E, Muszynski Z, Ciupinska M, Kotlinska-Lemieszek A . The pilot study assessing efficacy and versatility of novel therapy for neoplastic ulceration: clinical and microbiological aspects. Postepy Dermatol Alergol. 2013; 30(4):237-45. PMC: 3834706. DOI: 10.5114/pdia.2013.37034. View

18.

Svoboda V, Kovarik J, Morris F . High dose-rate microselectron molds in the treatment of skin tumors. Int J Radiat Oncol Biol Phys. 1995; 31(4):967-72. DOI: 10.1016/0360-3016(94)00485-4. View

19.

Kowalik L, Lyczek J, Sawicki M, Kazalski D . Individual applicator for brachytherapy for various sites of superficial malignant lesions. J Contemp Brachytherapy. 2013; 5(1):45-9. PMC: 3635046. DOI: 10.5114/jcb.2013.34340. View

20.

Mazeron J, Ghalie R, Zeller J, Marinello G, Marin L, Raynal M . Radiation therapy for carcinoma of the pinna using iridium 192 wires: a series of 70 patients. Int J Radiat Oncol Biol Phys. 1986; 12(10):1757-63. DOI: 10.1016/0360-3016(86)90316-0. View